The original version of this story appeared in Quanta Magazine. In 1939, upon arriving late to his statistics course at UC Berkeley, George Dantzig—a first-year graduate student—copied two problems ...

Sponsored Content. As power density soars, air and single-phase loops hit their limits. A new webinar from Advanced Cooling technologies (ACT) shows how loop thermosyphons and pumped two-phase cooling ...

Pritelivir demonstrated clinically meaningful and highly statistically significant superiority (p=0.0047) in lesion healing up to 28 days of treatment, compared with standard-of-care (SoC) treatments ...

The leading approach to the simplex method, a widely used technique for balancing complex logistical constraints, can’t get any better. In 1939, upon arriving late to his statistics course at the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Jim Irwin is doubling down on ...

HONOLULU (KHON2) — The second phase of Skyline has taken two years and three months, and it’s finally ready to open, with many expecting big changes to their commute. Skyline stations transform into ...

The biggest stories of the day delivered to your inbox.

After a couple of delays, Ashes of Creation ’s third Alpha Two phase is now live. The new phase comes with a fresh start for all players, 24/7 testing, and new content. With this big update, everyone ...

Crews will bore 1.8 miles of twin tunnels and build three new stations in East Harlem under the $7.7B Second Avenue Subway Phase 2 expansion, supported by seven shafts and precast concrete liners.

The contract, which will award nearly $2 billion to construction firms, funds crucial aspects of the latest phase of the long-awaited subway expansion into East Harlem. By Taylor Robinson Transit ...

Kansas Athletics received $300M from donor David Booth to fund stadium upgrades. City incentives and Booth's $75M challenge boost Phase 2 launch confidence. Renovations start post-2025 season; KU ...

Schrödinger has halted development of its cancer-fighting candidate SGR-2921 after two patients treated with the cell division cycle 7 (CDC7) inhibitor died in a Phase I trial. The trial (NCT05961839) ...